Trial results for new lung cancer drug ‘off the charts’, doctors say | Lung cancer

Doctors are hailing “off-the-charts” trial results that show a new drug has halted the progression of lung cancer for longer than any other treatment in medical history. Lung cancer is the leading cause of cancer death worldwide, accounting for approximately 1.8 million deaths each year. Survival rates for those with advanced forms of the disease, … Read more

A new lung cancer pill has been hailed as an off-the-charts success

By Kate Pickles Chicago Health Editor 13:01 31 May 2024, updated 15:29 31 May 2024 Patients with incurable lung cancer could have their lives extended by several years by a drug hailed as the “best ever” treatment for the disease. About six in ten patients given a daily tablet treated with lorlatinib survived five years … Read more